PROGRESS IN RETINAL AND EYE RESEARCH, published by PERGAMON-ELSEVIER SCIENCE LTD, is a premier journal dedicated to the advancement of knowledge in the fields of ophthalmology and sensory systems. With an impressive impact factor and a Q1 category ranking in both Ophthalmology and Sensory Systems as of 2023, this journal exemplifies excellence in research dissemination. Given its stature, it ranks #1 out of 137 in Ophthalmology and #1 out of 42 in Neuroscience - Sensory Systems, placing it within the top percentile of scientific publications in these domains. The journal has been actively contributing to the field since its inception in 1994 and continues to be a vital resource for researchers, clinicians, and students seeking the latest insights and breakthroughs in the understanding of retinal diseases and eye health. While it maintains a traditional subscription model, the journal remains committed to publishing high-quality, peer-reviewed articles that drive forward the frontiers of eye research and therapeutic innovation. With its strong scientific rigor and a vast array of articles, PROGRESS IN RETINAL AND EYE RESEARCH is indispensable for anyone invested in the study of visual sciences.

Strabismus is a distinguished journal published by Taylor & Francis Inc, dedicated to the field of ophthalmology, with a focus on the diagnosis, treatment, and research surrounding strabismic conditions. Since its inception in 1993, this journal has served as a pivotal platform for advancing knowledge and fostering discussion among researchers and clinicians alike, providing critical insights into the complexities of eye alignment disorders. With a current impact factor reflecting its solid standing in the Q3 quartile of ophthalmology journals, Strabismus continues to rank among the notable publications in its field, achieving a Scopus rank of #85 out of 137. Although it operates without an open access model, the journal is accessible to a broad audience of professionals through institutional subscriptions, ensuring that a wealth of research is available to support clinical practices. By encompassing a wide range of topics, from clinical studies to theoretical analyses, Strabismus aims to enhance understanding and improve patient outcomes, making it an essential resource for those engaged in ocular health and research.

Eye and Vision, published by BMC, is a leading open-access journal dedicated to the dynamic field of ophthalmology and visual sciences. With its ISSN 2326-0246 and E-ISSN 2326-0254, the journal has established itself as a premier platform for innovative research and clinical studies, achieving impressive rankings in 2023 as Q1 in both Health Professions (Miscellaneous) and Ophthalmology categories. The journal's commitment to accessible knowledge since its transition to open access in 2015 enhances its global reach, allowing researchers, clinicians, and students to share and access top-tier studies and advancements in the field. Located in the United Kingdom and delivering influential insights from 2014 through to 2024, Eye and Vision holds significant relevance, with a Scopus ranking placing it in the 99th percentile for Health Professions and the 93rd percentile for Ophthalmology, making it an essential resource for those looking to stay at the forefront of eye research and vision science.

Clinical Optometry is a prominent open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of ophthalmology and sensory systems. Established in 2010, this journal provides a platform for impactful research and insights that facilitate the understanding and treatment of visual disorders. With an impressive Scopus ranking of #58 in Ophthalmology and #28 in Neuroscience & Sensory Systems, Clinical Optometry is recognized for its contributions to the academic community, correlating with a Q3 classification in Ophthalmology and Q4 in Sensory Systems as of 2023. Based in New Zealand, this journal encourages researchers, professionals, and students to disseminate their findings, fostering a culture of knowledge sharing and collaboration in the field. For those interested in cutting-edge research, Clinical Optometry serves as an essential resource, offering a comprehensive collection of articles that enhance the understanding of ophthalmologic science.

African Vision and Eye Health Journal is an esteemed publication dedicated to advancing the fields of ophthalmology, optometry, and public health across the African continent. Published by AOSIS, this journal serves as a vital platform for disseminating research, clinical practices, and educational advancements aimed at improving eye health and vision care. As an Open Access journal, it ensures that knowledge is freely accessible to researchers, healthcare professionals, and practitioners, fostering collaboration and innovation. With its ISSN 0378-9411 and E-ISSN 2410-3039, the journal is committed to enhancing the understanding of vision-related issues affecting diverse populations, making it an invaluable resource for those dedicated to the promotion of eye health in Africa. By providing cutting-edge research and insights, the African Vision and Eye Health Journal plays a critical role in addressing the challenges of eye health and is a key resource for anyone committed to making a difference in this essential field.

MOLECULAR VISION is a premier open-access journal that has been advancing the field of ophthalmology since its inception in 1995. Published by MOLECULAR VISION, this journal boasts a strong reputation, currently ranking in the second quartile (Q2) of its category, with a Scopus ranking of 35 out of 137, placing it in the 74th percentile among peer publications. Dedicated to disseminating groundbreaking research and innovative findings in the study of vision and ocular health, MOLECULAR VISION serves as a vital resource for researchers, healthcare professionals, and students engaged in this dynamic field. The journal welcomes contributions spanning fundamental and clinical research, offering a platform for crucial knowledge exchange that is essential for advancing ocular health and function. With its commitment to open access, readers around the globe can freely access and build upon the wealth of information disseminated through its pages, ensuring that the latest developments in ophthalmology are available to all.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, published by Springer, has established itself as a premier journal in the field of ophthalmology since its inception in 1870. With an ISSN of 0721-832X and an E-ISSN of 1435-702X, this esteemed journal enjoys a notable impact in the research community, ranking Q1 in Ophthalmology and Q1 in Sensory Systems, as per the latest 2023 journal category quartiles. GRAEFES Archive is dedicated to advancing our understanding of ocular health through both clinical and experimental studies, making it an essential resource for researchers, practitioners, and students alike. Its comprehensive scope covers various aspects of ophthalmic science, reflecting its long-standing commitment to quality and excellence. Although it currently operates on a subscription basis, the journal's significant Scopus rankings—24th out of 137 in Ophthalmology—underscore its relevance and influence within the scientific community. Situated in Germany, with its address in the United States, this international journal continues to shape the discourse on vision science and therapeutic innovation.

Contact Lens & Anterior Eye is a premier journal dedicated to advancing the field of optometry, ophthalmology, and overall visual health. Published by Elsevier, this journal boasts an impressive impact factor and is indexed with both ISSN 1367-0484 and E-ISSN 1476-5411. It stands out with a Q1 ranking in the categories of Medicine (miscellaneous), Ophthalmology, and Optometry, placing it at the forefront of scholarly research in its disciplines. With a comprehensive scope that encompasses the latest advancements in contact lens technology and anterior eye health, the journal serves as a crucial resource for researchers, healthcare professionals, and students aiming to enhance their knowledge and skills. The journal has been publishing cutting-edge research since its inception in 1997 and continues to pave the way in ophthalmic research through high-quality, peer-reviewed articles. Although it does not currently offer Open Access options, its availability through institutional subscriptions ensures that critical research reaches its intended audience effectively.

JOURNAL FRANCAIS D OPHTALMOLOGIE, published by MASSON EDITEUR, is a prominent peer-reviewed journal that serves as a vital resource in the field of ophthalmology. Launched in 1978, this esteemed publication continues to make significant contributions to the advancement of ocular health and vision science, with its scope encompassing clinical practices, innovative research, and the latest technological advancements in ophthalmic care. Based in France, the journal is recognized in the 2023 category quartiles with a Q3 ranking in ophthalmology, reflecting its dedication to quality scholarship within a competitive landscape, as evidenced by its positioning in the 30th percentile of the Scopus rankings. While it operates without Open Access, the journal remains crucial for professionals, researchers, and students alike, providing a platform for sharing knowledge and fostering collaborations in the global ophthalmological community.

American Journal of Ophthalmology, published by Elsevier Science Inc, stands as a premier outlet for significant advancements in the field of ophthalmology. Established in 1918, this journal has a long-standing tradition of disseminating high-quality research, which is reflected in its impressive Scopus ranking, positioned at #8 out of 137 in the ophthalmology category, placing it in the 94th percentile. With its 2023 designation as Q1 in Ophthalmology, it serves as a critical platform for researchers, practitioners, and students who seek to stay at the forefront of ocular health and visual science. Although the journal does not currently offer open access options, it provides an array of access formats, ensuring that valuable research is available to a broad audience dedicated to the exploration and understanding of eye diseases and treatments. As it continues to evolve towards 2024, the American Journal of Ophthalmology remains essential for anyone engaged in ophthalmic research and clinical practice.